T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.99% |
| 2 | Healthcare | 16.87% |
| 3 | Consumer Discretionary | 15.81% |
| 4 | Financials | 11.47% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNT
1226
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $13.3M | ﹤0.01% |
+921,822
| New | +$12.6M |
|
1227
MeiraGTx Holdings
MGTX
$1.17B
| $13.2M | ﹤0.01% |
+997,308
| New | +$13.1M |
|
|
PVBC
1228
DELISTED
Provident Bancorp
PVBC
| $13.1M | ﹤0.01% |
1,684,999
+10,009
| +0.6% | +$79.1K |
|
1229
Pentair
PNR
$10.5B
| $13.1M | ﹤0.01% |
285,974
-14,122
| -5% | -$615K |
|
1230
Bath & Body Works
BBWI
$3.76B
| $13.1M | ﹤0.01% |
507,780
+3,873
| +0.8% | +$79.2K |
|
|
CDR
1231
DELISTED
Cedar Realty Trust, Inc
CDR
| $13M | ﹤0.01% |
2,436,024
+809
| +0% | +$4.72K |
|
1232
Southern First Bancshares
SFST
$607M
| $13M | ﹤0.01% |
538,972
-24,390
| -4% | -$618K |
|
1233
Kirby Corp
KEX
$7.26B
| $12.9M | ﹤0.01% |
356,257
-57,803
| -14% | -$2.55M |
|
1234
F5
FFIV
$23.6B
| $12.9M | ﹤0.01% |
104,917
-4,304
| -4% | -$579K |
|
1235
Petrobras
PBR
$115B
| $12.9M | ﹤0.01% |
1,806,803
+361,804
| +25% | +$3.07M |
|
1236
Carnival Corporation Ltd
CCL
$38.9B
| $12.8M | ﹤0.01% |
844,295
-37,380
| -4% | -$578K |
|
1237
FS Bancorp
FSBW
$325M
| $12.8M | ﹤0.01% |
624,258
| – | – |
|
1238
Asbury Automotive
ABG
$3.76B
| $12.8M | ﹤0.01% |
131,082
+116,883
| +823% | +$11.8M |
|
|
ORTX
1239
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $12.7M | ﹤0.01% |
309,317
-181,995
| -37% | -$9.41M |
|
1240
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $12.7M | ﹤0.01% |
151,000
+2,000
| +1% | +$168K |
|
1241
Robert Half
RHI
$4.48B
| $12.6M | ﹤0.01% |
237,376
-167,242
| -41% | -$8.91M |
|
1242
Newell Brands
NWL
$2.63B
| $12.5M | ﹤0.01% |
728,657
-26,579
| -4% | -$443K |
|
1243
Stoke Therapeutics
STOK
$2.02B
| $12.4M | ﹤0.01% |
370,093
-21,265
| -5% | -$607K |
|
1244
Natera
NTRA
$45.5B
| $12.4M | ﹤0.01% |
171,277
-251,932
| -60% | -$14.3M |
|
1245
Ponce Financial Group
PDLB
$500M
| $12.3M | ﹤0.01% |
1,950,578
+1,049
| +0.1% | +$6.84K |
|
|
ISEE
1246
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $12.3M | ﹤0.01% |
2,177,224
-652,127
| -23% | -$3.11M |
|
1247
Williams-Sonoma
WSM
$28.9B
| $12.3M | ﹤0.01% |
271,270
-1,170
| -0.4% | -$52K |
|
|
SBT
1248
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $12.2M | ﹤0.01% |
4,038,635
-134,795
| -3% | -$430K |
|
1249
Prelude Therapeutics
PRLD
$428M
| $12.1M | ﹤0.01% |
+400,000
| New | +$11.3M |
|
1250
Kosmos Energy
KOS
$1.51B
| $12M | ﹤0.01% |
12,331,684
-1,623,779
| -12% | -$2.38M |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.